Abstract:In their normal in vivo matrix milieu, tissues assume complex well-organized three-dimensional architectures. Therefore, the primary aim in the tissue engineering design process is to fabricate an optimal analog of the in vivo scenario. This challenge can be addressed by applying emerging layered biofabrication approaches in which the precise configuration and composition of cells and bioactive matrix components can recapitulate the well-defined three-dimensional biomimetic microenvironments that promote cell-cell and cell-matrix interactions. Furthermore, the advent of and refinements in microfabricated systems can present physical and chemical cues to cells in a controllable and reproducible fashion unmatched with conventional cultures, resulting in the precise construction of engineered biomimetic microenvironments on the cellular length scale in geometries that are readily parallelized for high throughput in vitro models. As such, the convergence of layered solid freeform fabrication (SFF) technologies along with microfabrication techniques enables the creation of a three-dimensional micro-organ device to serve as an in vitro platform for cell culture, drug screening or to elicit further biological insights, particularly for NASA's interest in a flight-suitable high-fidelity microscale platform to study drug metabolism in space and planetary environments. The proposed model in this paper involves the combinatorial setup of an automated syringe-based, layered direct cell writing bioprinting process with micro-patterning techniques to fabricate a microscale in vitro device housing a chamber of bioprinted three-dimensional liver cell-encapsulated hydrogel-based tissue constructs in defined design patterns that biomimic the cell's natural microenvironment for enhanced biological functionality. In order to assess the structural formability and biological feasibility of such a micro-organ, reproducibly fabricated tissue constructs were biologically characterized for liver cell-specific function. Another key facet of the in vivo microenvironment that was recapitulated with the in vitro system included the necessary dynamic perfusion of the three-dimensional microscale liver analog with cells probed for their collective drug metabolic function and suitability as a drug metabolism model. This paper details the principles and methods that undergird the direct cell writing biofabrication process development and adaptation of microfluidic devices for the creation of a drug screening model, thereby establishing a novel drug metabolism study platform for NASA's interest to adopt a microfluidic microanalytical device with an embedded three-dimensional microscale liver tissue analog to assess drug pharmacokinetic profiles in planetary environments.

On-Chip Construction of Liver Lobule-like Microtissue and Its Application for Adverse Drug Reaction Assay.

Synergistic Modulation of a Tunable Microenvironment to Fabricate a Liver Fibrosis Chip for Drug Testing.

Hydrogel Microfluidic‐based Liver‐on‐a‐chip: Mimicking the Mass Transfer and Structural Features of Liver

Design and fabrication of an integrated 3D dynamic multicellular liver-on-a-chip and its application in hepatotoxicity screening

A 3D bio-printed spheroids based perfusion in vitro liver on chip for drug toxicity assays

A pumpless liver-on-a-chip for drug hepatotoxicity analysis

Microengineered Bioartificial Liver Chip for Drug Toxicity Screening

Constructing biomimetic liver models through biomaterials and vasculature engineering

Construction and Application of 3D Microfluidic Liver-On-A-Chip

A Three-Dimensional (3D) Liver-Kidney on a Chip with a Biomimicking Circulating System for Drug Safety Evaluation.

An AC Electrothermal Self-Circulating System with a Minimalist Process to Construct a Biomimetic Liver Lobule Model for Drug Testing

Fabrication of Perfusable 3D Hepatic Lobule-Like Constructs Through Assembly of Multiple Cell Type Laden Hydrogel Microstructures

Construction of a Liver Sinusoid Based on the Laminar Flow on Chip and Self-Assembly of Endothelial Cells

On-microparticle construction of endothelialized liver microtissues for drug testing

Development of a Biomimetic Liver Tumor-on-a-chip Model Based on Decellularized Liver Matrix for Toxicity Testing.

Biofabrication of a Three-Dimensional Liver Micro-Organ As an in Vitro Drug Metabolism Model

Liver-on-a-Chip Integrated with Label-Free Optical Biosensors for Rapid and Continuous Monitoring of Drug-Induced Toxicity

Biomimetic Liver Lobules from Multi‐Compartmental Microfluidics

Microfluidic human physiomimetic liver model as a screening platform for drug induced liver injury

Microprinting of liver micro-organ for drug metabolism study.

A Cell Lines Derived Microfluidic Liver Model for Investigation of Hepatotoxicity Induced by Drug-Drug Interaction